| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | +492.8% |
| R&D Expense | $7.4M | -27.7% |
| SG&A Expense | $5.0M | +2.0% |
| Operating Income | -$1.2M | +93.6% |
| Pre-tax Income | $9K | +100.1% |
| Income Tax | $681 | -9.8% |
| Net Income | $8K | +100.1% |
| EPS (Basic) | -$3.10 | +0.0% |
| EPS (Diluted) | -$3.14 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | +30.1% |
| Current Assets | $22.3M | -2.4% |
| Total Assets | $22.5M | -2.1% |
| Current Liabilities | $1.5M | -42.5% |
| Total Liabilities | $1.5M | -42.5% |
| Stockholders' Equity | $21.0M | +3.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +89.7% |
| Capital Expenditures | $90K | +584.2% |
| Investing Cash Flow | $2.4M | -81.3% |
| Financing Cash Flow | $209K | -48.3% |
| Free Cash Flow | -$1.3M | +89.0% |
| +0.0% |